Federal health agencies have called for an immediate pause on the single-dose Johnson & Johnson vaccine after six recipients in the United States have developed a rare disorder involving blood clots within two weeks of vaccination.
CDC and FDA reviewing data involving six reported U.S. cases of a rare type of blood clot in individuals after receiving Johnson & Johnson COVID-19 vaccine. See full statement: https://t.co/ekYT9dljtd pic.twitter.com/a7Fiixg735
— CDC (@CDCgov) April 13, 2021
All of the six recipients were women between the ages of 18 and 48.
One woman died and a second woman in Nebraska has been hospitalized in critical condition.
Dr. Peter Marks, director of the Food and Drug Administration’s Center for Biologics Evaluation and Research, and Dr. Anne Schuchat, principal deputy director of the C.D.C., said in a joint statement:
We are recommending a pause in the use of this vaccine out of an abundance of caution. Right now, these adverse events appear to be extremely rare.
Nearly seven million people in the United States have already received the Johnson & Johnson vaccine and nine million more doses have been shipped out to the states.
I don’t even play with Johnson & Johnson powder…I darn sure wasn’t messing with their vaccine.
Your thoughts?
Source: NY Times
Discover more from Ice Cream Conversations
Subscribe to get the latest posts sent to your email.
